title: Application of French prognostic score to patients with International Prognostic Scoring System intermediate-2 or high risk myelodysplastic syndromes treated with 5-azacitidine is able to predict overall survival and rate of response.
authors: Massimo
authors: M
authors: Breccia
authors: Giuseppina
authors: G
authors: Loglisci
authors: Laura
authors: L
authors: Cannella
authors: Paola
authors: P
authors: Finsinger
authors: Marco
authors: M
authors: Mancini
authors: Alessandra
authors: A
authors: Serrao
authors: Michelina
authors: M
authors: Santopietro
authors: Adriano
authors: A
authors: Salaroli
authors: Giuliana
authors: G
authors: Alimena
mesh_terms: D001374:Azacitidine / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality; D011379:Prognosis; D018570:Risk Assessment; D015996:Survival Rate
chemical_list: D001374:Azacitidine